FDA Approved: ONFI — Original Application (Lundbeck Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved ONFI (clobazam) through an original NDA for use as adjunctive therapy for seizures associated with Lennox-Gastaut syndrome in patients 2 years …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lennox-gastaut Syndrome

Drugs mentioned

• ONFI (clobazam)

Snippet

ORIG AP for ONFI (CLOBAZAM)